Medikabazaar
PrivateLast Round
Early Funding
Feb 19, 2024
Est. Valuation
$700M
Total Funding Raised
$169.01M
Company Overview
Medikabazaar operates in Healthcare & Life Sciences and is based in Mumbai. Its latest recorded funding round was a Series D round in April 2022.
Medikabazaar is a health technology company that operates a B2B online marketplace for the procurement of medical equipment, devices, and supplies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, E-commerce, Supply Chain, Medical Imaging, Pharma Supply Chain
Business Model
B2B
Customer Profile
Marketplace Commission, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medikabazaar Comparables
Compare Medikabazaar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmEasy | 82% | |
| Smart Medical Buyer | 82% | |
| Hospital Store | 76% |
For institutional investors. Book with your work email.
Medikabazaar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 19, 2024 | ||||
| Series D | Apr 12, 2022 | ||||
| Series C | Sep 22, 2021 | ||||
| Series B Extension | Jun 18, 2020 | ||||
| Series B Extension | Mar 11, 2020 | ||||
Series B | Nov 18, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medikabazaar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MS&AD Ventures | Series C |
| Ackermans & van Haaren | Series B Extension, Series D, Early Funding, Series C, Series B |
| Sasaki Foods | Series A |
| Catalytic Impact Foundation | Series C |
| KOIS | Series D, Series B, Series C, Series A |
| Nepean Capital | Series D |
| CBC Group | Series D, Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Launched India's first 640-slice AI-powered CT scanner.
- Jul 1, 2025
Apollo Hospitals and Fortis Healthcare referenced as clients.
For institutional investors. Book with your work email.
Medikabazaar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medikabazaar's valuation, stock price, and market status.
Is Medikabazaar a public or private company?
Medikabazaar is a private company.
What is the current stock price of Medikabazaar?
Medikabazaar is a private company, so its shares have no public market price. Caplight tracks Medikabazaar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medikabazaar worth (valuation)?
Medikabazaar's valuation is estimated at $700.0M based on funding round data.
Can I buy Medikabazaar stock?
Medikabazaar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medikabazaar's last funding round?
Medikabazaar's most recent funding round was Early Funding on February 19, 2024.
Who are the main investors in Medikabazaar?
Key investors in Medikabazaar include Ackermans & van Haaren, CBC Group, Rebright Partners, Creaegis, HealthQuad.
Will Medikabazaar IPO soon?
No public IPO plans have been announced for Medikabazaar.
How can I track Medikabazaar secondary market activity?
Caplight tracks bids, offers, and trades in Medikabazaar's shares on secondary markets.